• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指南 422a:绝经:血管舒缩症状、处方治疗药物、补充和替代医学、营养和生活方式。

Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle.

机构信息

Edmonton, AB.

Winnipeg, MB.

出版信息

J Obstet Gynaecol Can. 2021 Oct;43(10):1188-1204.e1. doi: 10.1016/j.jogc.2021.08.003. Epub 2021 Aug 11.

DOI:10.1016/j.jogc.2021.08.003
PMID:34390867
Abstract

OBJECTIVE

Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence.

TARGET POPULATION

Perimenopausal and postmenopausal women.

BENEFITS, HARMS, AND COSTS: Target population will benefit from the most recent published scientific evidence provided via the information from their health care provider. No harms or costs are involved with this information since women will have the opportunity to choose among the different therapeutic options for the management of the symptoms and morbidities associated with menopause, including the option to choose no treatment.

EVIDENCE

Databases consulted were PubMed, MEDLINE, and the Cochrane Library for the years 2002-2020, and MeSH search terms were specific for each topic developed through the 7 chapters.

VALIDATION METHODS

The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See online Appendix A (Tables A1 for definitions and A2 for interpretations of strong and weak recommendations). INTENDED AUDIENCE: physicians, including gynaecologists, obstetricians, family physicians, internists, emergency medicine specialists; nurses, including registered nurses and nurse practitioners; pharmacists; medical trainees, including medical students, residents, fellows; and other providers of health care for the target population.

SUMMARY STATEMENTS

RECOMMENDATIONS.

摘要

目的

根据最新发表的证据,为围绝经期和绝经后妇女的护理提供策略。

目标人群

围绝经期和绝经后妇女。

获益、危害和成本:目标人群将受益于通过医疗保健提供者提供的最新发表的科学证据。由于妇女将有机会在与绝经相关的症状和疾病的管理的不同治疗选择中进行选择,包括选择不治疗的选择,因此不会涉及此信息的危害或成本。

证据

咨询的数据库为 2002-2020 年的 PubMed、MEDLINE 和 Cochrane 图书馆,并且每个章节都开发了特定的主题,使用了 MeSH 搜索词。

验证方法

作者使用推荐评估、制定和评估(GRADE)方法对证据质量和推荐强度进行了评级。请参阅在线附录 A(表 A1 用于定义,表 A2 用于解释强弱推荐)。

目标受众

医生,包括妇科医生、产科医生、家庭医生、内科医生、急诊医生;护士,包括注册护士和执业护士;药剂师;医学实习生,包括医学生、住院医师、研究员;以及目标人群的其他医疗保健提供者。

总结陈述

建议。

相似文献

1
Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle.指南 422a:绝经:血管舒缩症状、处方治疗药物、补充和替代医学、营养和生活方式。
J Obstet Gynaecol Can. 2021 Oct;43(10):1188-1204.e1. doi: 10.1016/j.jogc.2021.08.003. Epub 2021 Aug 11.
2
Guideline No. 422g: Menopause and Osteoporosis.指南第 422g 条:绝经与骨质疏松症。
J Obstet Gynaecol Can. 2022 May;44(5):527-536.e5. doi: 10.1016/j.jogc.2021.09.013.
3
Guideline No. 422e: Menopause and Cardiovascular Disease.第422e号指南:更年期与心血管疾病。
J Obstet Gynaecol Can. 2021 Dec;43(12):1438-1443.e1. doi: 10.1016/j.jogc.2021.09.010. Epub 2021 Nov 17.
4
Guideline No. 422f: Menopause and Breast Cancer.第422f号指南:更年期与乳腺癌。
J Obstet Gynaecol Can. 2021 Dec;43(12):1450-1456.e1. doi: 10.1016/j.jogc.2021.09.011. Epub 2021 Nov 17.
5
Guideline No. 422b: Menopause and Genitourinary Health.指南 422b:绝经和生殖泌尿系统健康。
J Obstet Gynaecol Can. 2021 Nov;43(11):1301-1307.e1. doi: 10.1016/j.jogc.2021.09.001. Epub 2021 Sep 8.
6
Guideline No. 422c: Menopause: Mood, Sleep, and Cognition.指南第 422c 号:绝经:情绪、睡眠和认知。
J Obstet Gynaecol Can. 2021 Nov;43(11):1316-1323.e1. doi: 10.1016/j.jogc.2021.08.009. Epub 2021 Nov 4.
7
Guideline No. 422d: Menopause and Sexuality.指南 422d:绝经与性生活。
J Obstet Gynaecol Can. 2021 Nov;43(11):1334-1341.e1. doi: 10.1016/j.jogc.2021.09.005. Epub 2021 Sep 16.
8
No. 385-Indications for Pelvic Examination.第385号——盆腔检查的适应症
J Obstet Gynaecol Can. 2019 Aug;41(8):1221-1234. doi: 10.1016/j.jogc.2018.12.007.
9
Guideline No. 451: Asymptomatic Endometrial Thickening in Postmenopausal Women.指南 451:绝经后妇女无症状性子宫内膜增厚。
J Obstet Gynaecol Can. 2024 Jul;46(7):102591. doi: 10.1016/j.jogc.2024.102591. Epub 2024 Jun 18.
10
Guideline No. 425a: Cannabis Use Throughout Women's Lifespans - Part 1: Fertility, Contraception, Menopause, and Pelvic Pain.指南第 425a 号:女性一生中的大麻使用 - 第 1 部分:生育力、避孕、绝经和盆腔痛。
J Obstet Gynaecol Can. 2022 Apr;44(4):407-419.e4. doi: 10.1016/j.jogc.2022.01.012.

引用本文的文献

1
Prevalence and impact of vasomotor symptoms due to menopause among women in Canada: A subgroup analysis from an international cross-sectional survey of Women with Vasomotor Symptoms Associated with Menopause (WARM Study).加拿大女性绝经后血管舒缩症状的患病率及影响:一项针对绝经相关血管舒缩症状女性的国际横断面调查(WARM研究)的亚组分析。
Menopause. 2025 Jan 1;32(1):38-44. doi: 10.1097/GME.0000000000002451.
2
Development and validation of a case definition for problematic menopause in primary care electronic medical records.开发和验证初级保健电子病历中绝经相关问题的病例定义。
BMC Med Inform Decis Mak. 2023 Oct 5;23(1):202. doi: 10.1186/s12911-023-02298-x.
3
[Not Available].
[无可用内容]。
CMAJ. 2023 Jul 31;195(29):E989-E995. doi: 10.1503/cmaj.221438-f.
4
Cannabis use for menopause in women aged 35 and over: a cross-sectional survey on usage patterns and perceptions in Alberta, Canada.35 岁及以上女性更年期使用大麻:加拿大艾伯塔省横断面调查使用模式和认知
BMJ Open. 2023 Jun 21;13(6):e069197. doi: 10.1136/bmjopen-2022-069197.
5
Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial.口服微粒化黄体酮治疗围绝经期夜间盗汗和热潮红:一项为期 4 个月、加拿大全国范围、随机、安慰剂对照、III 期试验。
Sci Rep. 2023 Jun 5;13(1):9082. doi: 10.1038/s41598-023-35826-w.
6
Hormones and thrombosis: the dark side of the moon.激素与血栓形成:月亮的阴暗面。
Blood Transfus. 2024 Jan;22(1):46-54. doi: 10.2450/BloodTransfus.535. Epub 2023 Apr 27.
7
A pragmatic approach to the management of menopause.一种实用的更年期管理方法。
CMAJ. 2023 May 15;195(19):E677-E672. doi: 10.1503/cmaj.221438.
8
The Current Strategy in Hormonal and Non-Hormonal Therapies in Menopause-A Comprehensive Review.更年期激素与非激素疗法的当前策略——全面综述
Life (Basel). 2023 Feb 26;13(3):649. doi: 10.3390/life13030649.
9
Rapid recommendations: Updates from 2021 guidelines: part 2.快速推荐:2021年指南更新:第2部分
Can Fam Physician. 2022 Oct;68(10):754-756. doi: 10.46747/cfp.6810754.
10
Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women.非酒精性脂肪肝与瘦体重和超重绝经前妇女血管舒缩症状发生风险的关系。
Nutrients. 2022 Jul 8;14(14):2805. doi: 10.3390/nu14142805.